Skip to main content
HR 6885 116th Congress House Health Asia China Civil actions and liability Congressional oversight Drug safety, medical device, and laboratory regulation Employment and training programs Government information and archives Government trust funds Health information and medical records India Manufacturing Prescription drugs Tariffs Trade restrictions

Safe and Secure Medicine Supply for Hardworking Americans Act of 2020

Introduced: May 15, 2020 See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 15, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 15, 2020
Introduced in House
 Plain-English summary Congressional Research Service

Safe and Secure Medicine Supply for Hardworking Americans Act of 2020

This bill bans in certain instances the importation of drugs and medical devices from a foreign manufacturing facility that has been subject to a recall, imposes additional duties on imported drugs, and contains other related provisions.

The Food and Drug Administration shall ban drug or device imports from a foreign facility for a specified amount of time if a drug or device from that facility has been subject to a Class I or Class II recall. The bill imposes civil monetary fines for any individual or entity that violates such an import ban.

The bill also imposes, on top of any other duties, a 25% duty on drugs imported from China, a 20% duty on drugs imported from India, and a 10% duty on drugs imported from any other country.

The duties and fines established under this bill shall go into a fund for supporting and incentivizing new pharmaceutical or medical device manufacturing in the United States.

The bill also requires each drug sold to state on its label the country of origin of each active pharmaceutical ingredient.

What's happening now May 15, 2020

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Committees of jurisdiction 2